• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Catalog Number SE-06-030-120-6F
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Thrombosis (2100)
Event Date 10/19/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Implant date - estimated.The reported patient effects of thrombosis is listed in the supera instructions for use as a known patient effects associated with the use of the device.The device was not returned for evaluation.A review of the lot history record and complaint history could not be conducted because the lot numbers were not provided.Based on the information reviewed, there is no indication of a product quality issue.The investigation was unable to determine a conclusive cause for the reported stent migration and patient effects; however the treatment appears to be related to the circumstances of the procedure.The 6 x 60 mm supera referenced is being filed under separate medwatch report.
 
Event Description
It was reported the procedure was to treat a long thrombotic occlusion of a vein graft in the mid popliteal artery with a 6 x 30 mm and 6 x 60 mm supera stents this year in february.The patient suffered from popliteal artery entrapment syndrome (paes) which was treated from the vascular surgeons in 2015.A vein graft was implanted besides the native popliteal artery from p1 to p3 to disable the paes.The patient returned with the vein graft and supera stents occluded with thrombosis.Additionally, under fluoroscopy, the 6 x 60 mm supera stent was noted to be fractured and the 6 x 30 mm supera stent was dislocated proximally.A guide wire was not able to cross; therefore, the patient was sent to surgery.It seems that the paes still exists, and they now will try to disable it with a new vein graft landing near the trifurcation below the knee.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6111734
MDR Text Key60285897
Report Number2024168-2016-08068
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08975370022650
UDI-Public(01)08975370022650
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 11/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberSE-06-030-120-6F
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/24/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STENT: 6 X 60 MM SUPERA
Patient Outcome(s) Hospitalization; Required Intervention;
-
-